Search clinical trials for: Typhoid Vi Polysaccharide Vaccine

Total 465283 results

National Jewish Health

Unknown

Pneumococcal Post-Vaccination Titers

Smokers, Elderly, Asthma, COPD, Recurrent Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Virus Diseases | Bacterial Infections | Neisseria Meningitidis

Finland
Genentech, Inc.

Completed

A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate (SIERRA)

Rheumatoid Arthritis

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine

Typhoid Fever

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age

Typhoid Fever

United States, Vietnam
Queen Mary University of London

Completed

Investigation of the Influence of Gender on Cardiovascular Function

Cardiovascular Function

United Kingdom
Biogen

Completed

Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

Relapsing Forms of Multiple Sclerosis

United States
Sinovac Biotech Co., Ltd

Completed

Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly

Pneumococcal Infections

China
Merck Sharp & Dohme LLC

Completed

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

Pneumococcal Infection
National Institute of Allergy and Infectious Diseases...

Completed

A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infection

United States
Aghia Sophia Children's Hospital of Athens

Unknown

Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

HIV Infection
Beaumont Hospital

Completed

Seasonal Trends in Pneumococcal Carriage in COPD Patients (Helios)

Chronic Obstructive Pulmonary Disease (COPD)

Ireland
University of Siena
Catholic University of the Sacred Heart

Withdrawn

Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults

Pneumococcal Infections | HIV

Italy
Eli Lilly and Company

Completed

A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants

Healthy

United States
Novartis Vaccines

Completed

Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children

Haemophilus Influenzae Type b (Hib) Infection

China
University of Oxford

Completed

Understanding the Immune Response to Two Different Meningitis Vaccines

Meningitis | Meningococcal Disease | Septicaemia

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children

Meningitis | Meningococcal Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States
GlaxoSmithKline

Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Germany
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Air Force Military Medical University, China; Guangxi Center for Disease Control... and other collaborators

Unknown

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Meningitis, Meningococcal

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations

Meningitis | Meningococcal Infection

Canada
Beijing Chaoyang District Centre for Disease Control...

Unknown

Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

ACYW135 Meningococcal Polysaccharide Vaccine
Centre Oscar Lambret
Santelys Association

Unknown

Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304) (KETOCOL-1304)

Uterine Cervical Cancer | Upper Aerodigestive Tract Neoplasms

France
Pfizer

Completed

Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.

PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States, Chile
University of Birmingham
Wellcome Trust; University Hospital Birmingham NHS Foundation Trust

Unknown

Investigating the Immune System in chrONIC Kidney Disease. (SONIC)

Immune System Diseases | Chronic Kidney Disease

United Kingdom
Novartis Vaccines

Completed

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Meningococcal Disease | Meningococcal Meningitis

Spain, Brazil, Hungary, Peru
Sanofi Pasteur, a Sanofi Company

Completed

Immunology and Safety of Menactra® in Children in Saudi Arabia

Meningitis | Meningococcemia

Saudi Arabia
Sanofi Pasteur, a Sanofi Company

Completed

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

Meningitis | Meningococcemia

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States, Puerto Rico
Institut National de la Santé Et de la Recherche...

Terminated

"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency (EVAD)

Common Variable Immunodeficiency

France
Jiangsu Province Centers for Disease Control and...
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

Hepatitis A

China
Novartis Vaccines
Novartis

Completed

Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

Meningococcal Meningitis

Finland, Poland
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Unknown

Polysaccharide Antibody Response Study (PARS)

Specific Polysaccharide Antibody Deficiency

Belgium
University of Florida

Completed

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23 (StatVax)

Healthy Controls

United States
University of Toledo Health Science Campus
National Institute on Aging (NIA)

Completed

Pneumonia Vaccine in Aging HIV Positive Individuals

Pneumococcal Infection

United States
Beijing Minhai Biotechnology Co., Ltd

Completed

Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine

Meningitis

China
Beijing Minhai Biotechnology Co., Ltd

Completed

Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine

Meningitis

China
University of Toledo Health Science Campus
National Institutes of Health (NIH)

Completed

Immune Response to Pneumococcal Vaccination in HIV Infected Individuals

Pneumococcal Infection

United States
National Institute on Aging (NIA)

Completed

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

Aging

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia

Meningococcal Infections | Neisseria Meningitidis

Saudi Arabia
Pfizer

Completed

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Neisseria Meningitidis (Bacterial Meningitis) | Invasive Pneumococcal Disease (IPD)

Germany
Pfizer

Completed

NeisVac-C Single Prime Study in Infants

Neisseria Meningitidis

Poland, Spain
Pfizer

Completed

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Meningitis, Meningococcal

Austria, Germany
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease (PNEUMO)

Pulmonary Disease, Chronic Obstructive

United States
Children's National Research Institute
Pfizer

Completed

Comparison of Immunization Quality Improvement Dissemination Study (CIzQIDS)

Immunization | Hepatitis B Vaccine | Poliovirus Vaccine, Inactivated | DTaP Vaccine | MMR Vaccine | HIB-vaccine | Chickenpox Vaccine | Pneumococcal Polysaccharide Vaccine
JN-International Medical Corporation

Completed

Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Meningococcal Infections | Meningococcal Meningitis

United States
University of Oxford
Novartis Vaccines

Completed

Understanding the Immune Response to Meningitis Vaccines

Meningitis | Septicemia

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

Meningitis | Meningococcal Infection

United States

3

Subscribe